HRS4R
Vull donar

GERARD PARDO ALBIÑANA

Biobanc
Firma
GERARD PARDO-ALBIÑANA
Posició
Personal tècnic del Biobanc
Personal tècnic del Biobanc

Publicacions

Hauser SL, Bar-Or A, Cohen JA, Comi G, Correale J, Coyle PK, Cross AH, de Seze J, Leppert D, Montalban X, Selmaj K, Wiendl H, Kerloeguen C, Willi R, Li B, Kakarieka A, Tomic D, Goodyear A, Pingili R, Häring DA, Ramanathan K, Merschhemke M, Kappos L, ASCLEPIOS I and ASCLEPIOS II Trial Groups

Ofatumumab versus Teriflunomide in Multiple Sclerosis

NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383, 546-557 dx.doi.org/10.1056/NEJMoa1917246
Hauser SL, Bar-Or A, Comi G, Giovannoni G, Hartung HP, Hemmer B, Lublin F, Montalban X, Rammohan KW, Selmaj K, Traboulsee A, Wolinsky JS, Arnold DL, Klingelschmitt G, Masterman D, Fontoura P, Belachew S, Chin P, Mairon N, Garren H, Kappos L, OPERA I and OPERA II Clinical Investigators

Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis.

NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376, 221-234 dx.doi.org/10.1056/NEJMoa1601277
Montalban X, Hauser SL, Kappos L, Arnold DL, Bar-Or A, Comi G, de Seze J, Giovannoni G, Hartung HP, Hemmer B, Lublin F, Rammohan KW, Selmaj K, Traboulsee A, Sauter A, Masterman D, Fontoura P, Belachew S, Garren H, Mairon N, Chin P, Wolinsky JS, ORATORIO Clinical Investigators

Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis.

NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376, 209-220 dx.doi.org/10.1056/NEJMoa1606468
Moreno-Navarrete JM, Touskova V, Sabater M, Mraz M, Drapalova J, Ortega F, Serrano M, Catalán V, Gómez-Ambrosi J, Ortiz MR, Pardo G, Pueyo N, Ricart W, Lacinova Z, Haluzik M, Frühbeck G, Fernández-Real JM

Liver, but not adipose tissue PEDF gene expression is associated with insulin resistance.

INTERNATIONAL JOURNAL OF OBESITY, 2013, 37, 1230-1237 dx.doi.org/10.1038/ijo.2012.223
Moreno-Navarrete JM, Ortega F, Serrano M, Guerra E, Pardo G, Tinahones F, Ricart W, Fernández-Real JM

Irisin Is Expressed and Produced by Human Muscle and Adipose Tissue in Association With Obesity and Insulin Resistance

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2013, 98, 769-778 dx.doi.org/10.1210/jc.2012-2749
Moreno-Navarrete JM, Ortega F, Serino M, Luche E, Waget A, Pardo G, Salvador J, Ricart W, Frühbeck G, Burcelin R, Fernández-Real JM

Circulating lipopolysaccharide-binding protein (LBP) as a marker of obesity-related insulin resistance

INTERNATIONAL JOURNAL OF OBESITY, 2012, 36, 1442-1449 dx.doi.org/10.1038/ijo.2011.256
Moreno-Navarrete JM, Ortega FJ, Rodríguez-Hermosa JI, Sabater M, Pardo G, Ricart W, Fernández-Real JM

OCT1 Expression in Adipocytes Could Contribute to Increased Metformin Action in Obese Subjects

Diabetes, 2011, 60, 168-176 dx.doi.org/10.2337/db10-0805
Sabater M, Moreno-Navarrete JM, Ortega FJ, Pardo G, Salvador J, Ricart W, Frühbeck G, Fernández-Real JM

Circulating Pigment Epithelium-Derived Factor Levels Are Associated with Insulin Resistance and Decrease after Weight Loss

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2010, 95, 4720-4728 dx.doi.org/10.1210/jc.2010-0630
Ortega FJ, Moreno-Navarrete JM, Pardo G, Sabater M, Hummel M, Ferrer A, Rodriguez-Hermosa JI, Ruiz B, Ricart W, Peral B, Fernández-Real JM

MiRNA Expression Profile of Human Subcutaneous Adipose and during Adipocyte Differentiation

Plos One, 2010, 5 dx.doi.org/10.1371/journal.pone.0009022
Moreno-Navarrete JM, Botas P, Valdés S, Ortega FJ, Delgado E, Vázquez-Martín A, Bassols J, Pardo G, Ricart W, Menéndez JA, Fernández-Real JM

Val1483Ile in FASN gene is linked to central obesity and insulin sensitivity in adult white men.

Obesity, 2009, 17, 1755-1761 dx.doi.org/10.1038/oby.2009.65

Formulari de contacte

Coneix l’IDIBGI!

menu